Catalyst Pharmaceuticals, Inc. (FRA:CN2)
Germany · Delayed Price · Currency is EUR 20.53
+0.75 (3.79%)
At close: Jan 29, 2026
Catalyst Pharmaceuticals Market Cap
Catalyst Pharmaceuticals has a market cap or net worth of €2.51 billion as of January 30, 2026. Its market cap has decreased by -5.96% in one year.
Market Cap
2.51B
Enterprise Value
1.94B
Revenue
492.80M
Ranking
n/a
PE Ratio
13.56
Stock Price
€20.53
Market Cap Chart
Since November 8, 2006, Catalyst Pharmaceuticals's market cap has increased from 59.85M to 2.51B, an increase of 4,100.57%. That is a compound annual growth rate of 21.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.51B | 2.89% |
| Dec 31, 2025 | 2.44B | 1.62% |
| Dec 31, 2024 | 2.40B | 48.29% |
| Dec 29, 2023 | 1.62B | -10.49% |
| Dec 30, 2022 | 1.81B | 195.07% |
| Dec 31, 2021 | 613.84M | 116.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.48B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |